These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


505 related items for PubMed ID: 29725025

  • 1. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
    Jia Q, Bowen R, Dillon BJ, Masleša-Galić S, Chang BT, Kaidi AC, Horwitz MA.
    Sci Rep; 2018 May 03; 8(1):7009. PubMed ID: 29725025
    [Abstract] [Full Text] [Related]

  • 2. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.
    Jia Q, Horwitz MA.
    Front Cell Infect Microbiol; 2018 May 03; 8():154. PubMed ID: 29868510
    [Abstract] [Full Text] [Related]

  • 3. LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice.
    Tullius MV, Bowen RA, Back PS, Masleša-Galić S, Nava S, Horwitz MA.
    mBio; 2024 Apr 10; 15(4):e0018624. PubMed ID: 38511933
    [Abstract] [Full Text] [Related]

  • 4. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA.
    Infect Immun; 2010 Oct 10; 78(10):4341-55. PubMed ID: 20643859
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
    Tao P, Mahalingam M, Zhu J, Moayeri M, Sha J, Lawrence WS, Leppla SH, Chopra AK, Rao VB.
    mBio; 2018 Oct 16; 9(5):. PubMed ID: 30327445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
    Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN.
    Clin Vaccine Immunol; 2014 Feb 16; 21(2):212-26. PubMed ID: 24351755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
    De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.
    mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
    Kilgore PB, Sha J, Hendrix EK, Motin VL, Chopra AK.
    mBio; 2021 Dec 21; 12(6):e0322321. PubMed ID: 34872353
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.
    Vaccine; 2009 Sep 18; 27(41):5554-61. PubMed ID: 19651173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.